Free Trial

Annexon (ANNX) SEC Filings & 10K Form

$5.75
-0.07 (-1.20%)
(As of 09/6/2024 ET)

Recent Annexon SEC Filings

DateFilerForm TypeView
09/06/2024
3:30 PM
Annexon (Issuer)
Yednock Ted (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2024
9:15 AM
Annexon (Subject)
Yednock Ted (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/04/2024
3:34 PM
Annexon (Issuer)
Carson William H. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/30/2024
5:00 PM
Annexon (Issuer)
Yednock Ted (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/29/2024
1:08 PM
Annexon (Subject)
Yednock Ted (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/15/2024
11:15 PM
Annexon (Filer)
Form EFFECT
08/12/2024
3:59 PM
Annexon (Filer)
Form S-3
Registration statement under Securities Act of 1933  
08/12/2024
7:05 AM
Annexon (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/05/2024
6:53 PM
Annexon (Issuer)
Carson William H. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/05/2024
7:11 AM
Annexon (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/17/2024
3:46 PM
Annexon (Issuer)
Yednock Ted (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/17/2024
3:48 PM
Annexon (Issuer)
Lew Jennifer (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/17/2024
3:49 PM
Annexon (Issuer)
Overdorf Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/15/2024
2:38 PM
Annexon (Subject)
Overdorf Michael (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/15/2024
2:24 PM
Annexon (Subject)
Lew Jennifer (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/15/2024
2:25 PM
Annexon (Subject)
Yednock Ted (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/02/2024
4:43 PM
Annexon (Issuer)
Carson William H. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2024
4:14 PM
Annexon (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/12/2024
11:28 AM
Annexon (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/07/2024
8:41 PM
Annexon (Issuer)
Carson William H. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
8:42 PM
Annexon (Issuer)
Waddill William D. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
8:43 PM
Annexon (Issuer)
Choi Jung (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
8:44 PM
Annexon (Issuer)
Satter Muneer A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
8:45 PM
Annexon (Issuer)
WIGGANS THOMAS G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
8:40 PM
Annexon (Issuer)
Cockroft Bettina M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
3:42 PM
Annexon (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/06/2024
8:57 PM
Annexon (Filer)
Form 424B5
06/05/2024
3:23 PM
Annexon (Issuer)
Carson William H. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2024
4:21 PM
Annexon (Filer)
Form 424B5
06/04/2024
6:05 AM
Annexon (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/22/2024
7:35 PM
Annexon (Subject)
BB BIOTECH AG (Filed by)
Form SC 13G
04/10/2024
6:17 PM
Annexon (Issuer)
Carson William H. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2024
11:15 PM
Annexon (Filer)
Form EFFECT
03/26/2024
4:01 PM
Annexon (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/26/2024
4:05 PM
Annexon (Filer)
Form S-3
Registration statement under Securities Act of 1933  
03/26/2024
3:05 PM
Annexon (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/26/2024
3:10 PM
Annexon (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/20/2024
2:12 PM
Annexon (Subject)
Overdorf Michael (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/20/2024
2:12 PM
Annexon (Subject)
Lew Jennifer (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/20/2024
2:15 PM
Annexon (Subject)
Yednock Ted (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/14/2024
7:46 PM
Annexon (Subject)
Venrock Healthcare Capital Partners II, L.P. (Filed by)
Form SC 13G/A
The solution to fast food’s wage hike crisis (Ad)

Shake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase, according to the NY Post. With a sky-high 150% turnover rate, the fast food industry is already grappling with labor issues before taking into account these wage hikes. The industry will need a projected 1 million new workers every year through 2032.

Learn more about this much-needed advancement and investment opportunity here.
02/14/2024
6:56 PM
Annexon (Issuer)
Love Douglas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
6:59 PM
Annexon (Issuer)
Overdorf Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
6:52 PM
Annexon (Issuer)
Yednock Ted (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
6:54 PM
Annexon (Issuer)
Lew Jennifer (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
2:45 PM
Annexon (Subject)
Fairmount Funds Management LLC (Filed by)
Form SC 13G/A
02/14/2024
11:43 AM
Annexon (Subject)
EVENTIDE ASSET MANAGEMENT, LLC (Filed by)
Form SC 13G/A
02/14/2024
9:26 AM
Annexon (Subject)
BIOTECHNOLOGY VALUE FUND L P (Filed by)
Form SC 13G/A
02/13/2024
6:23 PM
Annexon (Subject)
Logos Global Management LP (Filed by)
Form SC 13G/A
02/13/2024
5:57 PM
Annexon (Subject)
Bain Capital Life Sciences Fund, L.P. (Filed by)
Form SC 13G/A
02/12/2024
2:39 PM
Annexon (Subject)
Yednock Ted (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/12/2024
2:40 PM
Annexon (Subject)
Lew Jennifer (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/12/2024
2:41 PM
Annexon (Subject)
Love Douglas (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/12/2024
2:45 PM
Annexon (Subject)
Overdorf Michael (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/07/2024
6:02 AM
ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by)
Annexon (Subject)
Form SC 13G/A
01/23/2024
3:57 PM
Annexon (Issuer)
Lew Jennifer (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2024
3:58 PM
Annexon (Issuer)
Overdorf Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2024
7:53 AM
Annexon (Subject)
FMR LLC (Filed by)
Form SC 13G
12/29/2023
3:12 PM
Annexon (Issuer)
Yednock Ted (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/28/2023
3:30 PM
Annexon (Issuer)
Annexon (Issuer)
Satter Muneer A (Reporting)
Satter Muneer A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/27/2023
3:50 PM
Annexon (Subject)
Yednock Ted (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/22/2023
4:28 PM
Annexon (Filer)
Form 8-K/A
12/20/2023
4:17 PM
Annexon (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/20/2023
4:24 PM
Annexon (Subject)
Form FWP
10/24/2023
3:30 PM
Annexon (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/11/2023
3:44 PM
Annexon (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:ANNX) was last updated on 9/7/2024 by MarketBeat.com Staff

From Our Partners